Beam Therapeutics Inc.
BEAM
$17.00
$0.382.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -376.74M | -143.59M | -143.01M | -134.74M | -132.53M |
| Total Depreciation and Amortization | 21.93M | 21.84M | 21.56M | 20.80M | 20.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 117.79M | 106.92M | 99.01M | 84.40M | 79.78M |
| Change in Net Operating Assets | -110.22M | -120.98M | -115.03M | -109.58M | -116.46M |
| Cash from Operations | -347.25M | -135.81M | -137.47M | -139.13M | -149.20M |
| Capital Expenditure | -8.95M | -9.57M | -15.94M | -30.15M | -33.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 193.95M | 166.39M | 137.83M | 23.08M | 105.57M |
| Cash from Investing | 185.01M | 156.83M | 121.90M | -7.08M | 71.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -485.00K | -1.12M | -1.32M | -1.83M | -2.25M |
| Issuance of Common Stock | 8.22M | 39.12M | 75.22M | 183.32M | 279.33M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -384.00K | -569.00K | -631.00K |
| Cash from Financing | 7.74M | 38.01M | 73.52M | 180.93M | 276.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.50M | 59.02M | 57.95M | 34.73M | 199.09M |